ResMed Inc (RMD)

Operating profit margin

		Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019
Operating income (ttm)	US$ in thousands	1,319,891	1,213,944	1,140,031	1,145,131	1,131,873	1,112,001	1,045,595	1,014,112	1,000,286	986,527	975,688	948,693	903,676	885,285	879,359	855,452	809,658	707,487	646,964	606,233
Revenue (ttm)	US$ in thousands	4,681,240	4,528,920	4,442,900	4,314,610	4,171,410	4,064,591	3,819,396	3,688,938	3,645,890	3,606,884	3,513,684	3,419,445	3,265,514	3,144,973	3,128,793	3,045,837	2,957,056	2,891,676	2,784,449	2,699,392
Operating profit margin		28.20%	26.80%	25.66%	26.54%	27.13%	27.36%	27.38%	27.49%	27.44%	27.35%	27.77%	27.74%	27.67%	28.15%	28.11%	28.09%	27.38%	24.47%	23.23%	22.46%

June 30, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $1,319,891K ÷ $4,681,240K
= 28.20%

ResMed Inc's operating profit margin has shown a generally positive trend over the past two years, with fluctuations from quarter to quarter. The operating profit margin increased from 22.46% in December 2019 to 28.20% in June 2024. This improvement indicates the company's ability to efficiently generate profit from its core operations. The margins remained relatively stable above 26% in recent quarters, reflecting consistent profitability. However, there were occasional slight dips in the margin, such as in March 2020 and September 2020, likely due to external factors or operational challenges. Overall, the upward trend in operating profit margin suggests effective cost management and revenue generation by ResMed Inc.